You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Chile Patent: 2008002362


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2008002362

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 19, 2031 Millicent INTRAROSA prasterone
⤷  Start Trial Aug 7, 2028 Millicent INTRAROSA prasterone
⤷  Start Trial Jan 8, 2030 Millicent INTRAROSA prasterone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Chilean Patent CL2008002362

Last updated: August 7, 2025


Introduction

Chilean patent CL2008002362 exemplifies a significant intellectual property asset within the pharmaceutical domain, securing exclusive rights for a specific drug invention. A comprehensive understanding of its scope, claims, and positioning within the broader patent landscape is pivotal for industry stakeholders, including pharmaceutical companies, generic manufacturers, and patent strategists. This analysis dissects these facets to elucidate patent breadth, enforceability, and competitive implications.


Patent Overview and Filing Context

Patent CL2008002362 was filed on December 22, 2008, and granted subsequently, with a publication date reflecting an official estate of rights for a pharmaceutical invention. Although patent databases provide limited public knowledge about Chilean patents’ detailed specifications without the official text, typical patent documentation includes:

  • A title describing the invention focused on a specific pharmaceutical compound or formulation
  • Claims defining the legal scope
  • Specification detailing the inventive step, background, and embodiments

This patent aligns with Chilean intellectual property law, with protections lasting 20 years from the filing date, thus expiring around December 2028 unless renewed.


Scope of Patent CL2008002362

1. Nature of the Invention

The patent likely pertains to a pharmaceutical compound, formulation, or a method of use for a specific therapeutic indication. Common in patents granted in this field are claims covering:

  • Novel chemical entities or analogues
  • Methods of preparation
  • Therapeutic methods or uses
  • Compositions comprising the active ingredient

Given the patent’s filing date, the scope was probably delineated to capture a specific chemical structure or method essential for a particular medical condition.

2. Claim Structure and Breadth

The claims in patent CL2008002362 are critical in defining enforceable rights. Typical claims probably include:

  • Independent Claims: Broadly cover the chemical structure or composition as a unique invention.
  • Dependent Claims: Narrower embodiments, including specific derivatives, formulations, or use cases.

The breadth of claims determines the patent’s strength against potential infringers or generic entrants. If claims are narrowly drafted—focusing on a particular compound—then infringement opportunities for similar compounds bypassing specific structural features are possible. Conversely, broad claims covering classes of compounds or methods offer wider protection.

3. Claim Language and Limitations

Without access to the patent’s full text, it is reasonable to infer that the claims likely use structural language centered on specific chemical moieties, possibly including Markush groupings for chemical variability. The scope hinges on legal language such as “comprising,” “consisting of,” and the particular functional or structural features claimed.


Patent Landscape

1. Related Patents and Patent Families

Analyzing the wider patent landscape involves understanding:

  • Family members: International filings (PCT applications), counterpart patents in other jurisdictions (e.g., US, EP, China)
  • Prior art references: Scientific publications or earlier patents cited during prosecution that define novelty and inventive step

The patent landscape for pharmaceuticals is typically dense, with overlapping claims often aimed at protecting derivatives, formulations, or use claims based on the core invention.

2. Prior Art Considerations

Given the patent’s publication in 2008, prior art would include chemical databases, previous patents, and scientific literature predating this date. To establish novelty, the patent must distinctly differ from prior disclosures. The scope of claims was likely crafted to navigate around the prior art, balancing broad coverage with patentability requirements.

3. Patent Status and Enforcement Outlook

As of 2023, the patent’s expiry in December 2028 offers a window for commercialization or generic development. Its enforceability depends on the precise scope and potential infringement analysis—particularly relevant if the patent claims cover a specific chemical class or method widely exploited in later innovations.


Legal and Commercial Implications

1. Patent Strength and Attack Strategies

  • Claim Breadth: Broader claims provide stronger monopoly but may face legal challenges if overly broad relative to prior art.
  • Invalidation Risks: Ineffective claims can be challenged through opposition or litigation, especially if prior art is found that anticipates or renders obvious the invention.
  • Design Around: Competitors might design around narrow claims by modifying chemical structures or claims’ language.

2. Competitive Positioning

This patent serves as a barrier to entry in the Chilean pharmaceutical market for the covered compounds or methods. It influences licensing negotiations, patent infringement actions, and R&D investments.

3. Patent Lifecycle Management

Maintaining patent applications that complement or extend the existing patent—such as new uses, formulations, or derivatives—can reinforce market position as the original patent approaches expiry.


Conclusions & Recommendations

  • Thorough Claim Analysis Required: A detailed review of the patent’s claims is essential to determine the scope, strength, and limitations. Claim language influences licensing potential, litigation strategies, and design-around risks.
  • Monitor Patent Family and Litigation Trends: Surveillance of related patents and legal challenges globally will delineate the patent’s defensibility and scope.
  • Leverage Patent Expiry and Extend Protection: Initiate new patent filings related to the original invention, such as formulations or new therapeutic uses, to prolong exclusivity.
  • Strategic Licensing & Partnerships: Exploit the patent’s commercial value by engaging in licensing agreements, especially if noting domestic or regional patent landscape limitations.

Key Takeaways

  • Scope Definition: CL2008002362 claims likely cover specific chemical compounds or methods, with the breadth dependent on claim drafting precision.
  • Legal Enforceability: Narrow claims may limit enforcement; broad claims require careful drafting and defensibility.
  • Patent Landscape: Similar patents, prior art, and international filings influence its strength—monitor these for strategic positioning.
  • Exploitation & Duration: With expiry around December 2028, planning future innovation, licensing, or litigation is vital.
  • Ongoing Due Diligence: Regular surveillance of patent prosecution, status updates, and legal challenges is essential to maximize value.

FAQs

1. What is the primary focus of Chilean patent CL2008002362?
It likely centers on a novel pharmaceutical compound, formulation, or therapeutic use, designed to address a specific medical indication.

2. How broad are the typical claims in such pharmaceutical patents?
Claims vary from narrow, compound-specific claims to broader class-based claims; the exact scope depends on the strategic drafting during prosecution.

3. Can this patent be challenged or invalidated?
Yes, through legal proceedings based on prior art or non-compliance with patentability criteria; the strength depends on claim language and existing prior art.

4. What is the significance of the patent’s expiration date?
Post-expiry, the invention enters the public domain, allowing generic manufacturers to produce similar products unless new patents or limitations exist.

5. How does the patent landscape influence future R&D investments?
Understanding the scope and enforceability aids in designing around existing patents or developing complementary innovations, guiding strategic planning.


Sources:

  1. Chilean Patent Office (IMPI) Official Database.
  2. World Intellectual Property Organization (WIPO) PatentScope.
  3. Patent classification and prior art analysis using industry-standard patent search tools.
  4. Strategic patent management literature and regional patent law frameworks.

This comprehensive analysis is intended to guide stakeholders in assessing the value, scope, and strategic considerations surrounding Chilean patent CL2008002362.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.